Pfizer & LABS waiting on 2 things before Pfizer cancommercialize new class of cancer drugs utilizing payload delivery with targeting mechanims. First, for interstate commerce purpose and corporate tax purposes, the DEA has to deschedule cannabis from 1 to 3. This now enables the FDA to approve things like the NDA, 505(b), and any other submissions from Pfizer & LABS.
This is a critical step in the process because there were over 20 strong clinical trials, many in late stage, that those steps will enable commercialization.
I hope everyone long in LABS has had the time to sit down before emotional excitement over takes the brain to do some serious financial planning on how they will direct their funds. Things like retirement planning, higher education planning, etc, before going out on a shopping spree and blowing it.
I can't stress the planning enough, especially for younger generations.